Investigation of staphylococcus strains with heterogeneous resistance to glycopeptides in a Turkish University Hospital

BMC Infectious Diseases

Volumn 5, Issue , 2005, Pages

  Nakipoglu, Yasar ^a   Derbentli, Sengul ^a   Katranci, Handan ^a   Cagatay, Atahan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ANTIBIOTIC AGENT; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLONY FORMING UNIT; CONTROLLED STUDY; DILUTION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INFUSION; INOCULATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POPULATION BIOLOGY; QUANTITATIVE ANALYSIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS HAEMOLYTICUS; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

EID: 25444530397     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-5-31     Document Type: Article

References (27)

1. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, Fukuchi Y, Kobayashi I: Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogenously resistant to vancomycin. Lancet 1997, 350: 1670-1673.
2. Srinivasan A, Dick JD, Perl T.M: Vancomycin Resistance in Staphylococci. Clin Microbiol Rev 2002, 15: 430-438.
3. Hiramatsu K, Ito T, Hanaki H: Vancomycin-Resistant Staphylococcus aureus (VRSA).1999. [http://www.ansorp.org/isaar/1999/symposium/5-Hiramatsu.pdf].
4. CDC: Staphylococcus aureus resistant to vancomycin-United States. Morb Mortal Wkly Rep 2002, 51: 565-567.
5. Liu C, Chambers HF: Staphylococcus aureus with heterogeneous resistance to vancomycin: Epidemiology, clinical significance, and critical assessment of diagnostic methods. Antimicrob Agents Chemother 2003, 47: 3040-3045.
6. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M7-A5. National Committee for Clinical Laboratory Standards 2000. Wayne, Pa.
7. Guerin F, Buu-Hoi A, Mainardi JL, Kac G, Colardelle N, Vaupre S, Gutmann L, Podglajen I: Outbreak of Methicillin-Resistant Staphylococcus aureus with reduced Susceptibility to Glycopeptides in a Parisian Hospital. J Clin Microbiol 2000, 38: 2985-2988.
8. Mulligan ME, Murray-Leisure KA, Ribner BS, Standiford HC, John JF, Korvick JA, Kauffman CA, Yu VL: Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993, 94: 313-328.
9. Cercenado E, Garcia-Leoni ME, Diaz MD, Sanchez-Carrillo C, Catalan P, De Quiros JC, Bouza E: Emergence of teicoplanin-resistant coagulase-negative staphylococci. J Clin Microbiol 1996, 34: 1765-1768.
10. Kloos WE, Bannerman TL: Staphylococcus and Micrococcus. In: PR Murray, EJ Baron, M.A Pfaller, FC Tenover, and RH Yolken (eds), Manual of clinical microbiology, 6th edn. Washington, D.C: American Society for Microbiology, 1995: 282-298.
11. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing, 11th informational supplement, Approved standard M100-S11. National Committee for Clinical Laboratory Standards 2001, 21, Wayne, Pa.
12. Hiramatsu K: Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet 2001,1: 147.
13. Shlaes DM, Shlaes JH, Vincent S, Etter L, Fey PD, Goering RV: Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex. Antimicrob Agents Chemother 1993, 37: 2432-2437.
14. Herwaldt L, Boyken L, Pfaller M: In vitro selection of resistance to vancomycin in bloodstream isolates of Staphylococcus haemolyticus and Staphylococcus epidermidis. Eur J Clinl Microbiol Infects Dis 1991, 10:1007-1012.
15. Schwalbe RS, Ritz WJ, Verma PR, Barranco EA, Gilligan PH: Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus. J Infect Dis 1990, 161: 45-51.
16. Schwalbe RS, Stapleton JT, Gilligan PH: Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987, 316: 927-931.
17. Ike Y, Arakawa Y, Ma X, Tatewaki K, Nagasawa M, Tomita H, Tanimoto K, Fujimoto S: Nationwide survey shows that meticillin-resistant Staphylococcus aureus strains heterogeneously and intermediately resistant to vancomycin are not disseminated throughout Japanese hospitals. J Clin Microbiol 2001, 39: 4445-4451.
18. Marchese A, Balistreri G, Tonoli E: Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains in a large Italian hospital. J Clin Microbiol 2001, 39: 866-869.
19. Bierbaum G, Fuchs K, Lenz W, Szekat C, Sahl HG: Presence of Staphyloccus aureus with reduced Susceptibility to Vancomycin in Germany. Eur J Clin Microbiol Infect Dis 1999, 18: 691-696.
20. Reverdy ME, Jarraud S, Bobin-Dubreux S, Burel E, Girardo P, Lina G, Vandenesch F, Etienne J: Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals. Clin Microbiol Infect 2001, 7: 267- 272.
21. Griethysen AV, Veen AV, Buiting A, Walsh T, Kluytmans J: High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in the Netherlands. J Clin Microbiol 2003, 41: 2487-2491.
22. Trakulsomboon S, Danchaivijitr S, Rongrungruang Y: First report of Methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomcin in Thailand. J Clin Microbiol 2001, 39: 591-595.
23. Kim MN, Hwang SH, Pyo YJ, Mun HM, Pai CH: Clonal Spread of Staphylococcus Heterogenously Resistant to Vancomycin in a University Hospital in Korea. J Clin Microbiol 2002, 40: 1376-1380.
24. Gruneberg RN, Hryniewiez W: Clinical relevance of a European collaborative study on comporative susceptibility of Gram-positive clinical isolates to teicoplanin and vancomycin. Int J Antimicrob Agents 1998, 10: 271-277.
25. Moellering RC: The spector of glycopeptide resistance: current trends and future consideration. Am J Med 1998, 104: 3S-6S.
26. Wong SS, Ho PL, Woo PC: Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin Infect Dis 1999, 24: 760-767.
27. Moore MR, Perdreau-Remington F, Chambers HF: Treatment faliure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents and Chemother 2003, 47: 1262-1266.